Navigation Links
TransTech Medical Solutions Expands Offering to MD Anderson Cancer Center to Include Outsourced Medical Transcription and Editing Services
Date:12/14/2010

HOUSTON, Dec. 14, 2010 /PRNewswire/ -- TransTech Medical Solutions is pleased to announce the expansion of their transcription services agreement with MD Anderson Cancer Center.  The new agreement increases the suite of services that TransTech provides to MD Anderson to include traditional transcription and voice recognition editing services across a variety of software platforms.  Information about the full range of medical transcription and editing services provided by TransTech can be found at http://www.transtechmedical.com.

"Our familiarity with the staff at TransTech, their consistently fast turnaround times, and their ability to provide customized solutions to meet our needs made continuing and expanding the relationship an easy choice," said Frances Rose, Assistant Director of Health Information Management for MD Anderson.  "Plus, we like that all of TransTech's services are performed by US Based Transcriptionists."

As part of the expanded services in the new agreement, TransTech will be providing voice recognition editing services for all radiologists working within the Hospital, in addition to the traditional transcription and voice recognition editing services that TransTech has been providing for the past four years.

"We're thrilled to expand our relationship with MD Anderson to provide additional outsourced transcription and editing services," said Tracy Boesch, President and COO of TransTech Medical Solutions.  "We look forward to providing the hospital with the fastest turnaround times in the industry and appreciate their confidence in us."

About TransTech Medical Solutions

TransTech Medical Solutions is an industry-leading provider of medical transcription and healthcare documentation services.  We provide our clients with innovative, advanced and customizable solutions. Our client base includes some of the nation's largest and most prestigious healthcare institutions. We offer quality, measurable turnaround times and verifiable pricing.  For more information visit http://www.transtechmedical.com.

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For seven of the past nine years, including 2010, MD Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.


'/>"/>
SOURCE TransTech Medical Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Leukemia & Lymphoma Society Targets Research in Four Critical Areas of Unmet Medical Need
2. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
3. CSA Medical Elects Todd Langevin to Board of Directors
4. MTEC Announces Release of NexGen Speech Recognition Editing and Medical Transcription Training Program
5. Medical Messengers AstralJet V4 Receives ONC-ATCB 2011/2012 Certification
6. Reportlinker Adds Medical Polymers Market to 2015 - Polyvinyl Chloride (PVC) Dominating the Medical Devices and Packaging Markets
7. Winner Medical Reports Fourth Quarter and Fiscal 2010 Results
8. Coast Career Institutes Expedited Training Program for Diagnostic Medical Sonography Helps Students Land the Highly Specialized Jobs They Seek
9. Streamline Health Solutions Enables Electronic Medical Records System for Leading Canadian Healthcare Provider
10. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
11. SI-BONE Adds Texas Back Institute Founder to Its Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):